<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report the response to, and toxicity of antithymocyte globulin (ATG) treatment in 11 consecutive patients (7 men and 4 women; median age 46 years) with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (AA) </plain></SENT>
<SENT sid="1" pm="."><plain>Six of the patients had severe disease and 5 had moderate disease; <z:hpo ids='HP_0000001'>all</z:hpo> were treated within one year from diagnosis </plain></SENT>
<SENT sid="2" pm="."><plain>The ATG regimen was the initial treatment for 6 patients, but a sequential treatment for the other 5 </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="4031">Cyclosporin A</z:chebi> was administered orally 1-3 weeks after the ATG treatment </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients were assessed for over 6 months (median, 20.4 months); 8 showed a good response, 1 a minimal response, and 2 no response </plain></SENT>
<SENT sid="5" pm="."><plain>Disease severity had no influence on the response </plain></SENT>
<SENT sid="6" pm="."><plain>In 1 patient, ATG treatment had to be discontinued because of hepatic toxicity </plain></SENT>
<SENT sid="7" pm="."><plain>However, adverse reactions were not severe in the other 10 patients </plain></SENT>
<SENT sid="8" pm="."><plain>These findings suggest that ATG treatment is a safe and effective therapy for AA </plain></SENT>
</text></document>